Then, we investigated the potential therapeutic effects of minocycline on the expression of two effective genes (CMKLR1 and INSR) in inflammation and glucose metabolism, hormonal profile, and ovarian histology in the PCOS NMRI mouse model. The gene discussed is INSR; the disease is polycystic ovary syndrome.